ANTIBODIES TO THROMBOPLASTIN IN SYSTEMIC LUPUS ERYTHEMATOSUS: ISOTYPE DISTRIBUTION AND CLINICAL SIGNIFICANCE IN A SERIES OF 92 PATIENTS

By Font J.   Lopez-Soto A.   Cervera R.   Casals F.J.   Reverter J.C.   Munoz F.J.   Miret C.   Bove A.   Ordinas A.   Ingelmo M.  

Thrombosis Research, Vol. 86, Iss. 1, 1997-04 ,pp. : 37-48

Elsevier

Access to resources Recommend Favorite

Prevalence and isotype distribution of antiphospholipid antibodies in unselected Chilean patients with venous and arterial thrombosis

By Palomo Iván   Pereira Jaime   Alarcón Marcelo   Vásquez Marcela   Pinochet Carmen   Vélez María   Sandoval Jorge   Icaza Gloria   Pierangeli Silvia  

Clinical Rheumatology, Vol. 23, Iss. 2, 2004-04 ,pp. : 129-133

Springer Publishing Company

Access to resources Recommend Favorite

Clinical features of Behçet's disease in patients in the Sultanate of Oman; the significance of antiphospholipid antibodies?

By El-Ageb E.M.   Al-Maini M.H.   Al-Shukaily A.K.   Al-Farsi Y.   Richens E.R.  

Rheumatology International, Vol. 21, Iss. 5, 2002-03 ,pp. : 176-181

Springer Publishing Company

Access to resources Recommend Favorite

Incidence of the Factor V Leiden-mutation, Coagulation Inhibitor Deficiency, and Elevated Antiphospholipid-antibodies in Patients with Preeclampsia or HELLP-Syndrome

By von Tempelhoff G.-F.   Heilmann L.   Spanuth E.   Kunzmann E.   Hommel G.  

Thrombosis Research, Vol. 100, Iss. 4, 2000-11 ,pp. : 363-365

Elsevier

Access to resources Recommend Favorite

Tissue factor pathway inhibitor (TFPI) activity in uremic patients during hemodialysis

By Cella G.   Vianello A.   Rampin E.   Sbarai A.   Boeri G.   Vertolli U.   Naso A.   Strauss W.E.  

Thrombosis Research, Vol. 81, Iss. 6, 1996-03 ,pp. : 671-677

Elsevier

Access to resources Recommend Favorite